Botox Expands Use to Migraine and Spasticity
Featured

Botox Expands Use to Migraine and Spasticity

Clinic Moves

Botox Expands Use to Migraine and Spasticity
Clinic Moves
August 28, 2026

Botox Expands Use to Migraine and Spasticity

Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing...

FDA Approves New Treatments for Brain Disorders
Clinic Moves
August 22, 2026

FDA Approves New Treatments for Brain Disorders

FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam...

Website Users Unable to Access Content After Blocking
Clinic Moves
August 21, 2026

Website Users Unable to Access Content After Blocking

New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson...

Drug Approvals

Read our latest Drug Approvals articles.

UN health talks amid disease fears and leadership race
Drug Approvals August 17, 2026

UN health talks amid disease fears and leadership race

Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes,...

Law on assisted dying must be changed
Drug Approvals August 16, 2026

Law on assisted dying must be changed

Greens Senator introduces bill to change assisted dying law to allow telehealth access, improving access...

Outbreak Watch

Trial Briefs

All Posts

Botox Expands Use to Migraine and Spasticity
Clinic Moves

Botox Expands Use to Migraine and Spasticity

Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing a targeted alternative to systemic...

FDA approves Avulux lenses for migraine photophobia
Outbreak Watch

FDA approves Avulux lenses for migraine photophobia

FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine sufferers aged 12+, complementing existing...

FDA Halts RGX-121 Gene Therapy for MPS II
Outbreak Watch

FDA Halts RGX-121 Gene Therapy for MPS II

Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after MRI scans revealed spinal abnormalities,...

Factor XIa Inhibitors Show Promise in Stroke Prevention
Drug Approvals

Factor XIa Inhibitors Show Promise in Stroke Prevention

Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...

FDA Approves New Treatments for Brain Disorders
Clinic Moves

FDA Approves New Treatments for Brain Disorders

FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.

Website Users Unable to Access Content After Blocking
Clinic Moves

Website Users Unable to Access Content After Blocking

New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...

Policymaking toolkit exposes privilege disparities
Outbreak Watch

Policymaking toolkit exposes privilege disparities

Researchers develop toolkit to address policymaking privilege disparities and inequities in public policy decisions.

Architects of the hunt design deadly strategies
Trial Briefs

Architects of the hunt design deadly strategies

Architects of the hunt design deadly strategies in media regulation. Sign the open letter calling for a public inquiry into...

UN health talks amid disease fears and leadership race
Drug Approvals

UN health talks amid disease fears and leadership race

Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes, escalating political tensions.

Law on assisted dying must be changed
Drug Approvals

Law on assisted dying must be changed

Greens Senator introduces bill to change assisted dying law to allow telehealth access, improving access for medically supported voluntary assisted...

Show More →